10/19/2005 5:13:02 PM
LAS VEGAS--(BUSINESS WIRE)--March 16, 2005--Samaritan Pharmaceuticals Inc. (AMEX:LIV):
-- A Great Deal of Hope Rests with Non-embryonic Stem cell Therapy, (in contrast to controversial embryonic stem cell therapy where stem cells are transplanted from embryos or bone marrow.)
-- Non-embryonic Stem cell Therapy Activates Dormant Brain Stem cells in the Patient's Own Brain.
-- Samaritan's Drugs could Someday Allow Doctors to Grow and Re-grow Lost cells without Resorting to Surgery.
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs announced today it has developed a video to conceptualize its promising neural stem cell drugs. Samaritan optimistically believes its self renewing; differentiating, neural stem cell drugs to be therapeutic and possibly cure diseases, such as, Alzheimer's, Parkinson's and Spinal Cord Injuries.
comments powered by